Series C funding round for ALX Oncology raising $110M in February 2020
Series C funding round for ALX Oncology raising $110M in February 2020
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Carol Gallagher |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$146M
Top Valuation
-
ALX Oncology raised $110M in a Series C round.
The round was announced on 02/01/20.